Table 1.
Clinical characteristics of women enrolled in the present study.
| Variables | For WB assay |
For IHC assay |
||||||
|---|---|---|---|---|---|---|---|---|
| Normal proliferative (n = 6) | Normal mid-secretory (n = 14) | RIF mid-secretory (n = 14) | P value | Normal proliferative (n = 6) | Normal mid-secretory (n = 12) | RIF mid-secretory (n = 12) | P value | |
| Age (y) | 29.3 ± 2.3 | 30.1 ± 3.7 | 31.9 ± 2.1 | 0.15 | 29.3 ± 2.3 | 30.1 ± 3.7 | 31.9 ± 2.1 | 0.15 |
| BMI (kg/m2) | 20.7 ± 2.2 | 21.2 ± 1.8 | 20.3 ± 2.3 | 0.65 | 20.7 ± 2.2 | 21.2 ± 1.8 | 20.3 ± 2.3 | 0.65 |
| Basal FSH (IU/L) | 7.8 ± 0.98 | 7.8 ± 0.96 | 7.2 ± 0.85 | 0.43 | 7.8 ± 0.98 | 7.8 ± 0.96 | 7.2 ± 0.85 | 0.43 |
| Basal LH (IU/mL) | 4.3 ± 1.3 | 4.1 ± 1.5 | 3.8 ± 1.3 | 0.73 | 4.3 ± 1.3 | 4.1 ± 1.5 | 3.8 ± 1.3 | 0.73 |
| Basal E2 (pmol/mL) | 35.7 ± 10.8 | 35.9 ± 16.0 | 38.9 ± 16.9 | 0.89 | 35.7 ± 10.8 | 35.9 ± 16.0 | 38.9 ± 16.9 | 0.89 |